Nicolas Roelofs

Boreal Genomics, Inc. develops and markets DNA and RNA purification, enrichment, and detection equipment and tools. It provides research tools and developing diagnostic tests based on non invasive tumor profiling and monitoring of cancer. The company’s OnTarget platform performs sensitive genomic analysis of cell free DNA in plasma to detect and quantify mutations in tumor derived circulating nucleic acids. The company was founded by Andre Marziali, Jason Donald Thompson, Joel Pel and David J. Broemeling in 2007 and is headquartered in Vancouver, Canada.

Nordic Capital Ltd. (Nordic Capital) is a private equity subsidiary of Triona Holding SA founded in 1989 by Robert Andreen and Morgan Olsson. The firm is headquartered in St Hellier, New Jersey.

Stratagene Corp. researches, develops and markets diagnostic products and technologies for life science research. The company's products are used in the research of amplification, cell biology, cloning, microarrays, nucleic acid analysis, protein function and analysis, and quantitative PCR. Its clients include the industrial and government research sectors. The firm sells its products in more than 60 countries. Stratagene was founded in 1984 and is located in La Jolla, CA.

LGC Ltd. engages in the provision of scientific tool and solutions. It offers genomic analysis tools, drug development solutions, national laboratory, and health research program management. The company was founded in 1842 and is headquartered in Middlesex, the United Kingdom.

Life Technologies Clinical Services Lab, Inc. offers clinically guided personal genetic testing services for customers. The firm develops and commercializes genetics-based products and services to enhance individual health and wellness; and educates and empowers individuals and their physicians by providing personalized genetic insights about disease risk and medication response to catalyze behavior change and inform clinical decision-making. The company was founded by David B. Agus and Dietrich A. Stephan in 2006 and is headquartered in Foster City, CA.

Exploit Technologies Pte Ltd. operates as intellectual property portfolio company. It is a technology company which transfer arm of the Agency for Science, Technology and Research. Exploit Technologies and is headquartered in Singapore.

The Binding Site Group Ltd. engages in the development of medical equipment. It provides specialist diagnostic products to clinicians and laboratory professionals worldwide. Its products include freelite and hevylite; analysers and software; immunoassays; and manufacturing components. The company was founded by Jo Bradwell in 1983 and is headquartered in Birmingham, the United Kingdom.

Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland.

Insilixa, Inc. develops molecular diagnostic platform. It offers CMOS biochips for microarray technology, qPCR, and DNA sequencing. The company was founded by Arun Manickam and Arjang Hassibi in 2012 and is headquartered in Sunnyvale, CA.

Clear Labs, Inc. provides services related to food quality. The firm offers clear view platform, GMO test and WGS test products. The company was founded by Sasan Amini and Mahni Ghorashi in 2014 and is headquartered in San Carlos, CA.

Bluebee Holding BV engages in the development of a private cloud-based accelerated genomics platform. It supports cross-functional teams of life science researchers and clinicians by effectively centralizing and managing their genomics data processes and storage needs. The company was founded in 2011 by Vlad-Mihai Sima, Koen Bertls, Luk Wayne, and Zaid Al-Ars and is headquartered in Rijswijk, the Netherlands.

Summa Equity AB (Summa Equity) is a private equity firm founded in 2016 by Jenny Keisu, Reynir Kjær Indahl and Johannes Hidle Lien. The firm is headquartered in Stockholm, Sweden.

LGC Science Group Holdings Ltd. operates as an international life sciences business. It offers genomics solutions, reference materials, proficiency testing and analytical products and services. The company was founded on December 4, 2015 and is headquartered in Middlesex, the United Kingdom.

Founded in 2018, Thermo Fisher Scientific Blade I Ltd. is a British company that provides professional, scientific, and technical services. Part of Thermo Fisher Scientific, Inc., the private company is based in Edgbaston, UK.

One BioMed Pte Ltd. provides integrated molecular diagnostics services. The firm develops portable point-of-care diagnostic system, where doctors and patients will no longer have to wait for days for samples to be sent to a central laboratory for tests. The company was founded by Mi-Kyoung Park in 2015 and is headquartered in Singapore.

Biopath Ventures (Biopath Ventures) is a venture capital firm founded in 2018 by Joseph Jeong. The firm is headquartered in Millbrae, California.

Scale Biosciences, Inc. is an American single-cell sequencing solutions company that aims to unlock the potential of single-cell analysis at scale by eliminating barriers to discovery. The private company has R & D facilities in Menlo Park, CA and another location that is not specified. The company is located in the US. Scalebio is financed by leading life sciences tools investors Arch Venture Partners, BNG, and Tao Capital. The company's multidisciplinary team of scientists and technologists has combined expertise in next-generation sequencing, genomics, proteomics, and bioinformatics. Discover how their single-cell sequencing technology enables scalable sample indexing, cell throughput, and multi-omics analysis.

DA32 Life Science Tech Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on April 16, 2021 and is headquartered in New York, NY.

M51 Topco, Inc., through its subsidiary Velsera, is a company that connects healthcare and life sciences to enable precision medicine. The company is based in Boston, MA, and has subsidiaries in the United States and Belgium. The company aims to create a continuous flow of knowledge between researchers, scientists, and clinicians worldwide to improve human health. Velsera's focus is on creating insights that can radically improve human health. Gavin Nichols has been the CEO of the company since 2022.